for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated bacteria in the following conditions: Intra-Abdominal Infections, Uncomplicated and complicated skin and skin
structure infections, Female Pelvic Infections, Community and hospital
acquired pneumonia (moderate severity only), Nosocomial pneumonia
(moderate to severe), septicemia, Complicated infections involving the
urinary-tract, infections in neutropenic patients.
1 x 1s